Patrick Veit-Haibach, MD
- Deputy Chief / PMD (UHN sites)
- Division Head, Abdominal
Patrick Veit-Haibach is a dual-certified Radiologist and Nuclear Medicine Physician currently serving as the Director of the PET/MR program and Division Head Abdominal Imaging at the Joint Department Medical Imaging (JDMI), Toronto, Canada. He is Associate Professor of Radiology and Nuclear Medicine at the Department Medical Imaging at UoT. He completed his training in radiology and nuclear medicine in Germany and in Switzerland. Before joining the JDMI in 2017, he served as the head of the PET/CT-MRI section at the University Hospital Zurich, Switzerland.
His research interests focus on multi-modality molecular imaging strategies, particularly combined PET/MRI and PET/CT, perfusion- and hypoxia-imaging. Current projects involve clinical and preclinical molecular imaging research in esophago-gastric cancer, breast cancer, HCC, sarcoma, ENT cancer and lymphoma as well as technical evaluations in hybrid imaging.
- Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma
No abstract
- Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression
Aim: The aim of this meta-regression was to assess the impact of mean/median age, mean/median tumor size, percentage of males in total sample, and […]
- Prognostic Value of Sarcopenia and Metabolic Parameters of 18F-FDG-PET/CT in Patients with Advanced Gastroesophageal Cancer
We investigated the prognostic value of sarcopenia measurements and metabolic parameters of primary tumors derived from ^(18)F-FDG-PET/CT among […]
- The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer
CONCLUSION: The combined [^(18)F]-DCFPyL PET/MRI radiomic model was the best-performing model and outperformed the clinical model for pathological […]
- Standardized classification schemes in reporting oncologic PET/CT
The imaging report is essential for the communication between physicians in patient care. The information it contains must be clear, concise with […]
- 18F-FDG PET/MRI in Detection of Pulmonary Malignancies: A Systematic Review and Meta-Analysis
Background There have been conflicting results regarding fluorine 18-labeled fluorodeoxyglucose (^(18)F-FDG) PET/MRI diagnostic performance in lung […]
- CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling
We investigate whether computed tomography (CT) derived radiomics may correlate with driver gene mutations in patients with pancreatic ductal […]
- Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer
CONCLUSIONS: The GRIm-Score had the highest accuracy in predicting early death and OS. Clinicians may use this score to identify patients at higher […]
- Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer
We investigated, whether 18[18F]-FDG PET/CT-derived radiomics combined with sarcopenia measurements improves survival prognostication among patients […]
- Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma
CONCLUSION: Our study demonstrated that PET/CT-based radiomic features may improve survival prognostication among NPC patients when combined with […]
- 18F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study
CONCLUSION: Although ^(18)F-DCFPyL has higher specificity than CT in detecting advanced HGSOC tumor sites, it detects less disease sites than CT, […]
- Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up
CONCLUSIONS: This study with long-term follow up data on NPC suggests that mainly PET-derived radiomic features are predictive for OS but not PFS in […]
- Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma
INTRODUCTION: Metastatic gastroesophageal adenocarcinoma (GEA) is a heterogeneous disease with an overall poor prognosis. The impact of sites of […]
- Diagnostic performance of [18F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis
CONCLUSION: This meta-analysis showed an overall high diagnostic performance for [^(18)F]-FDG PET/MR in detecting CRC lesions/metastases. Thus, this […]
- Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer
Background Data regarding 2-(3-{1-carboxy-5-[(6-[^(18)F]fluoro-pyridine 3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (^(18)F-DCFPyL) PET in […]
- Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis
Background There is limited consensus regarding the relative diagnostic performance of cardiac MRI and fluorodeoxyglucose (FDG) PET for cardiac […]
- Combined 18 F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer
CONCLUSIONS: PET and CT radiomics derived from combined PET/CT integrated with clinicopathological parameters and sarcopenia measurement might […]
- The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis
CONCLUSION: In conclusion, PSMA PET is positive in more than 2/3 of men with BCR and impacts patient management in more than half of the men. BRFS […]
- Reproducibility of Standardized Uptake Values Including Volume Metrics Between TOF-PET-MR and TOF-PET-CT
CONCLUSION: PET metrics on TOF-PET-MR showed a good correlation with that of TOF-PET-CT. SUVmax and SUVpeak of tumor lesions were underestimated by […]
- Preoperative and Postoperative Approaches to Gastroesophageal Cancer: What is All the Fuss About
Gastroesophageal cancers carry poor prognoses, and are a leading cause of cancer-related morbidity and mortality worldwide. Even in those with […]
- The clinical consequences of functional adrenal uptake in the absence of cross-sectional mass on FDG-PET/CT in oncology patients
CONCLUSIONS: Thresholds of SUVmax and SUVratio identified a significant proportion of patients who did not develop adrenal metastasis. In oncology […]
- Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
CONCLUSIONS: Combined cardiac FDG-PET/MRI with T1/T2 mapping provides complementary diagnostic information and predicts MACE in patients with […]
- The association between lesion tracer uptake on 68Ga-DOTATATE PET with morphological response to 177Lu-DOTATATE therapy in patients with progressive metastatic neuroendocrine tumors
CONCLUSION: In patients with SSTR-RADS 5 PM-NETs treated with 177Lu-DOTATATE, there was similar response to therapy for all lesions with […]
- 68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement
CONCLUSION: This study showed a substantial interobserver agreement in the overall interpretation and detecting locoregional and distant involvement […]
- Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer
CONCLUSION: Combining the patients' imaging-derived sarcopenic status with standard clinical data, but not metabolic parameters, offered an overall […]
- 18F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center
CONCLUSION: ^(18)F-DCFPyL PET was positive in >90% of patients with biochemical failure. For those with limited recurrence, PSMA PET-directed […]
- A Path to Qualification of PET/MRI Scanners for Multicenter Brain Imaging Studies: Evaluation of MRI-Based Attenuation Correction Methods Using a Patient Phantom
PET/MRI scanners cannot be qualified in the manner adopted for hybrid PET/CT devices. The main hurdle with qualification in PET/MRI is that […]
- Neuroendocrine Tumors: Imaging Perspective
This article summarizes the role of PET imaging for detection, characterization, and theranostic/therapy planning for neuroendocrine tumors. Topics […]
- Pitfalls on PET/MRI
A decade of PET/MRI clinical imaging has passed and many of the pitfalls are similar to those on earlier studies. However, techniques to overcome […]
- Deep learning for whole-body medical image generation
CONCLUSION: The findings reported here demonstrate the feasibility of this technique and its potential to improve certain aspects of attenuation […]